TNFerade, an innovative cancer immunotherapeutic

about

The effects of tumor necrosis factor-α (TNF-α) rs1800629 and rs361525 polymorphisms on sepsis risk.

P2860

Q49270196-66840BED-3AD2-422C-881C-6336BCA2C977

P2860

TNFerade, an innovative cancer immunotherapeutic

Item

http://www.wikidata.org/entity/Q26776326

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

TNFerade, an innovative cancer immunotherapeutic

@ast

TNFerade, an innovative cancer immunotherapeutic

@en

TNFerade, an innovative cancer immunotherapeutic

@nl

type

Item

label

TNFerade, an innovative cancer immunotherapeutic

@ast

TNFerade, an innovative cancer immunotherapeutic

@en

TNFerade, an innovative cancer immunotherapeutic

@nl

prefLabel

TNFerade, an innovative cancer immunotherapeutic

@ast

TNFerade, an innovative cancer immunotherapeutic

@en

TNFerade, an innovative cancer immunotherapeutic

@nl

P1476

TNFerade, an innovative cancer immunotherapeutic

@en

P2093

Arunava Kali

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

The future of gene therapy.

A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer

The study of aqueous extract of Ficus religiosa Linn. on cytokine TNF-α in type 2 diabetic rats.

EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study.

Radiation therapy: activation for gene transcription and the development of genetic radiotherapy-therapeutic strategies in oncology.

Technology evaluation: TNFerade, GenVec.

Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer

Future chemotherapy and radiotherapy options in head and neck cancer.

Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results

P304

479-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.4103/0253-7613.165190

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26600634

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

immunotherapy

peptide

Tumor necrosis factor

blood proteins

biomedical investigative technique

P932

4621666

http://www.w3.org/2001/XMLSchema#string

TNFerade, an innovative cancer immunotherapeutic

about

P2860

P2860

TNFerade, an innovative cancer immunotherapeutic

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932